Parkisons Disease

Roche/Genentech PARAISO Why is the study needed? Paraiso is study to compare prasinezumab with a placebo in people with early-stage Parkinson’s disease who are taking levodopa to manage their disease symptomsParkinson’s disease (PD) is a long-term condition that gets worse over time. In PD, a naturally occurring protein called alpha-synuclein does not form properly. It sticks together […]